{{multiple issues|
{{primary sources|date=July 2012}}
{{advert|date=July 2012}}
}}
{{Infobox company 
| name   = Merz Pharma GmbH & Co. KGaA.
| logo   = 
| type   = [[Private company|Private]]
| traded_as      = 
| key_people     = {{unbulleted list| Andreas Krebs, [[Chairman]], Philip Burchard, [[Chief Executive Officer]]}}
| industry       = [[Pharmaceutical company|Pharmaceuticals]]
| products       = [[Xeomin]], [[Mederma]], [[Solvex]] 
| revenue = €1,157 million (2014-2015) <ref name=cws>Company website [https://www.merz.com/about-merz/facts-figures/] accessed October 27, 2016</ref>
| assets = 
| equity = 
| num_employees  = 2754 <ref name=cws />
| foundation     = 09 March 1908
| location       = [[Frankfurt am Main]]
| homepage       = {{URL|http://www.merz.com}}
}}

'''Merz Pharma [[GmbH]] & Co. [[KGaA]]''' is an international healthcare company specializing in over-the-counter and prescription creams, ointments and injectables in the fields of dermatology, neurology and metabolic disorders.<ref>http://www.newsobserver.com/2014/07/16/4009902/merz-pharma-establishing-hq-in.html</ref> Based in [[Frankfurt am Main]], Germany, Merz is a leader in the field of [[Alzheimer's disease]] research and developed [[memantine]] as the first drug for the treatment of moderate to severe Alzheimer's disease.<ref>{{cite web|title=Research & Development|url=http://www.merz.com/research_and_development/index.jsp|website=Merz.com|publisher=Merz|accessdate=27 June 2014}}</ref> Other franchises covered by Merz are hepatology / metabolic diseases and dermatology (including [[Mederma]] scar gel). In Asia Pacific, the Merz franchise covers aesthetic dermatology (including Radiesse and [[Botulinum toxin|Xeomin]]).

Merz was founded in 1908, has over 2700 employees and had 994 million euros of sales in 2013-14. The US subsidiary of Merz is '''Merz Pharmaceuticals LLC''' which was located in [[Greensboro, North Carolina]]. However, Merz has recently decided to move to [[Raleigh, North Carolina]].<ref>http://www.newsobserver.com/2014/07/16/4009902/merz-pharma-establishing-hq-in.html</ref>

Merz Pharma is considered to be a leader in the aesthetics, [[dermatology]] and neurosciences markets and it consolidated its position by the $600 million purchase of niche aesthetics [[medical device]] maker, Ulthera.<ref>http://www.bizjournals.com/triad/news/2014/06/26/merz-buying-medical-device-company-ulthera-for.html</ref> 

==History==
Merz Pharma [[GmbH]] & Co. [[KGaA]] was founded in 1908 by Friedrich Merz, a pharmacist by training. In 1909, the company moved to a new location at Eckenheimer Landstraße. 


== External links ==
* http://www.merz.com

==References==
{{Reflist}}

[[Category:Manufacturing companies based in Frankfurt]]
[[Category:Pharmaceutical companies of Germany]]
[[Category:Pharmaceutical companies established in 1908]]
[[Category:1908 establishments in Germany]]
[[Category:Medical and health organisations based in Hesse‎]]